Showing results (51-60 of 215) with videos related to

Sort By:
Pageof 22
TH Open : Companion Journal to Thrombosis and Haemostasis|July 9, 2021
Role of Increased Lipoprotein (a) in Retinal Vein Occlusion: A Systematic Review and Meta-analysisFrancesco Paciullo, David Giannandrea, Gianni Virgili, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2011
Inhibition of COX-1 activity and COX-2 expression by 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its semi-synthetic derivativesSalvatore Genovese, Massimo Curini, Paolo Gresele, et al.
Platelets|December 22, 2020
Search for SARS-CoV-2 RNA in platelets from COVID-19 patientsLoredana Bury, Barbara Camilloni, Roberto Castronari, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 8, 2005
Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016)Teresa Corazzi, Mario Leone, Raffaella Maucci, et al.
Reviews in Cardiovascular Medicine|July 3, 2014
Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterationsPaolo Gresele, Emanuela Falcinelli, Stefania Momi, et al.
Blood Advances|August 29, 2022
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AMLGiulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, et al.
Pharmacological Reports : PR|February 25, 2025
Effects of 3,5,4'-tri-[4-(nitrooxy)butanoyl]oxy resveratrol, a new nitric oxide-releasing derivative of resveratrol, on platelet activationGiuseppe Guglielmini, Emanuela Berardi, Federica Messina, et al.
Thrombosis and Haemostasis|March 6, 2007
Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudicationPaolo Gresele, Rino Migliacci, Alessandra Procacci, et al.
Biochemical and Biophysical Research Communications|November 19, 2003
Effect of nitric oxide-donating agents on human monocyte cyclooxygenase-2Teresa Corazzi, Mario Leone, Rita Roberti, et al.
Haematologica|December 7, 2005
Interactions between thrombophilic genetic mutations and clinical bleeding in patients on chronic oral anticoagulant treatmentLuigi Castori, Maria Rita Taliani, Giancarlo Agnelli, et al.
Pageof 22